|
PA8849001A1
(es)
|
2008-11-21 |
2010-06-28 |
Lilly Co Eli |
Anticuerpos de c-met
|
|
WO2011110642A2
(en)
|
2010-03-10 |
2011-09-15 |
Genmab A/S |
Monoclonal antibodies against c-met
|
|
AU2011261161A1
(en)
*
|
2010-06-01 |
2013-01-10 |
Ludwig Institute For Cancer Research Limited |
Antibodies directed to the unprocessed receptor tyrosine kinase c-Met
|
|
SG10201408229WA
(en)
|
2010-08-31 |
2015-02-27 |
Genentech Inc |
Biomarkers and methods of treatment
|
|
WO2012030842A2
(en)
|
2010-09-03 |
2012-03-08 |
Academia Sinica |
Anti-c-met antibody and methods of use thereof
|
|
BR122014027420A2
(pt)
|
2010-11-03 |
2019-08-20 |
Argenx Bvba |
Anticorpos anti c-met
|
|
CN102276726B
(zh)
*
|
2011-03-16 |
2014-02-19 |
常州新泉生物医药科技有限公司 |
肝细胞生长因子受体活性基团的融合蛋白
|
|
WO2012174529A2
(en)
*
|
2011-06-17 |
2012-12-20 |
Indiana University Research And Technology Corporation |
Methods for increasing the potency and efficacy of stem cells
|
|
WO2013043715A1
(en)
|
2011-09-19 |
2013-03-28 |
Genentech, Inc. |
Combination treatments comprising c-met antagonists and b-raf antagonists
|
|
US9201074B2
(en)
|
2011-09-20 |
2015-12-01 |
Eli Lilly And Company |
Anti-c-Met antibodies
|
|
KR20130036993A
(ko)
*
|
2011-10-05 |
2013-04-15 |
삼성전자주식회사 |
ｃ-Ｍｅｔ의 ＳＥＭＡ 도메인 내의 에피토프에 특이적으로 결합하는 항체
|
|
KR20130037153A
(ko)
*
|
2011-10-05 |
2013-04-15 |
삼성전자주식회사 |
항 ｃ-Ｍｅｔ 항체 및 그의 용도
|
|
KR101865223B1
(ko)
*
|
2011-10-05 |
2018-06-08 |
삼성전자주식회사 |
항 ｃ-Ｍｅｔ 인간화 항체 및 그의 용도
|
|
WO2013064700A2
(en)
|
2011-11-03 |
2013-05-10 |
Argen-X B.V. |
Chimeric polypeptides and methods of use
|
|
MX2014005885A
(es)
|
2011-11-21 |
2014-09-04 |
Genentech Inc |
Purificacion de anticuerpos anti-c-met.
|
|
WO2013079973A1
(en)
|
2011-12-02 |
2013-06-06 |
Di Cara Danielle Marie |
Antibodies against hgf - receptor and uses
|
|
CN104334581B
(zh)
*
|
2012-05-09 |
2018-02-02 |
伊莱利利公司 |
抗‑c‑Met抗体
|
|
JP6429771B2
(ja)
*
|
2012-06-21 |
2018-11-28 |
ソレント・セラピューティクス・インコーポレイテッドＳｏｒｒｅｎｔｏ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． |
ｃ−Ｍｅｔに結合する抗原結合タンパク質
|
|
EP2708556B1
(en)
*
|
2012-09-12 |
2018-11-07 |
Samsung Electronics Co., Ltd |
Pharmaceutical composition for the use in a combination therapy for prevention or treatment of c-met or angiogenesis factor induced diseases
|
|
ES2738310T3
(es)
|
2012-10-12 |
2020-01-21 |
Medimmune Ltd |
Pirrolobenzodiazepinas y conjugados de las mismas
|
|
KR20150118159A
(ko)
|
2013-02-22 |
2015-10-21 |
에프. 호프만-라 로슈 아게 |
암의 치료 방법 및 약물 내성의 예방 방법
|
|
CA2905181C
(en)
|
2013-03-13 |
2020-06-02 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof for providing targeted therapy
|
|
KR102049990B1
(ko)
*
|
2013-03-28 |
2019-12-03 |
삼성전자주식회사 |
c-Met 항체 및 VEGF 결합 단편이 연결된 융합 단백질
|
|
KR102042174B1
(ko)
*
|
2013-03-29 |
2019-11-08 |
삼성전자주식회사 |
인간화 및 친화도 성숙된 항 ｃ-Ｍｅｔ 항체 및 그의 용도
|
|
JP6491642B2
(ja)
*
|
2013-04-30 |
2019-03-27 |
エージェンシー フォー サイエンス， テクノロジー アンド リサーチ |
ｍＡｂ２抗Ｍｅｔ抗体
|
|
WO2015023503A2
(en)
*
|
2013-08-14 |
2015-02-19 |
Primeradx, Inc. |
Compositions and methods for multimodal analysis of cmet nucleic acids
|
|
KR20160067966A
(ko)
*
|
2013-10-14 |
2016-06-14 |
얀센 바이오테크 인코포레이티드 |
시스테인 조작된 피브로넥틴 iii형 도메인 결합 분자
|
|
US9717715B2
(en)
|
2013-11-15 |
2017-08-01 |
Samsung Electronics Co., Ltd. |
Method of combination therapy using an anti-C-Met antibody
|
|
TW201609805A
(zh)
|
2013-12-23 |
2016-03-16 |
美國禮來大藥廠 |
結合ｅｇｆｒ及ｍｅｔ之多功能抗體
|
|
TW201622744A
(zh)
*
|
2014-03-04 |
2016-07-01 |
美國禮來大藥廠 |
癌症之組合療法
|
|
MX2016012285A
(es)
|
2014-03-24 |
2017-01-23 |
Genentech Inc |
Tratamiento de cáncer con antagonista de c-met y correlación de estos con la expresión de hgf.
|
|
MX2016015163A
(es)
|
2014-05-23 |
2017-03-03 |
Genentech Inc |
Biomarcadores mit y metodos para su uso.
|
|
US10188746B2
(en)
|
2014-09-10 |
2019-01-29 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
ES2748295T3
(es)
|
2014-09-16 |
2020-03-16 |
Symphogen As |
Anticuerpos anti-MET y composiciones
|
|
EP3229836B1
(en)
|
2014-12-09 |
2019-11-13 |
Institut National de la Sante et de la Recherche Medicale (INSERM) |
Human monoclonal antibodies against axl
|
|
WO2016135041A1
(en)
|
2015-02-26 |
2016-09-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Fusion proteins and antibodies comprising thereof for promoting apoptosis
|
|
WO2016149265A1
(en)
*
|
2015-03-16 |
2016-09-22 |
Kolltan Pharmaceuticals, Inc. |
Anti-met antibodies and methods of use thereof
|
|
US10344071B2
(en)
|
2015-07-28 |
2019-07-09 |
Musc Foundation For Research Development |
Identification of novel anti-fibrotic peptide in C-terminal region of the MET receptor tyrosine kinase
|
|
AU2016349152A1
(en)
|
2015-11-03 |
2018-06-14 |
Merck Patent Gmbh |
Bi-specific antibodies for enhanced tumor selectivity and inhibition and uses thereof
|
|
CN106810611A
(zh)
*
|
2015-11-30 |
2017-06-09 |
中国科学院深圳先进技术研究院 |
抗cMet和CD3特异性双靶向抗体及其制备方法和应用、含该双靶向抗体表达盒的微环DNA及应用
|
|
ES2896709T3
(es)
|
2016-02-05 |
2022-02-25 |
Helixmith Co Ltd |
Anticuerpos anti-c-Met y usos de los mismos
|
|
GB2551372A
(en)
*
|
2016-06-16 |
2017-12-20 |
Bombardier Primove Gmbh |
A secondary unit, a system for inductive power transfer and a method for operating a secondary unit and a system for inductive power transfer
|
|
AU2017281083B2
(en)
|
2016-06-21 |
2022-01-27 |
Janssen Biotech, Inc. |
Cysteine engineered fibronectin type III domain binding molecules
|
|
CN107573416A
(zh)
*
|
2016-06-30 |
2018-01-12 |
中国科学院深圳先进技术研究院 |
抗igf1r和cd3特异性双靶向抗体、含该双靶向抗体表达盒的微环dna及应用
|
|
CN107556386A
(zh)
*
|
2016-06-30 |
2018-01-09 |
中国科学院深圳先进技术研究院 |
抗EGFRvIII和CD3特异性双靶向抗体、含双靶向抗体表达盒的微环DNA及应用
|
|
CN107556387A
(zh)
*
|
2016-06-30 |
2018-01-09 |
中国科学院深圳先进技术研究院 |
抗gpc3和cd3特异性双靶向抗体、含该双靶向抗体表达盒的微环dna及应用
|
|
CN107556388A
(zh)
*
|
2016-06-30 |
2018-01-09 |
中国科学院深圳先进技术研究院 |
抗CD44v6和CD3特异性双靶向抗体、含该双靶向抗体表达盒的微环DNA及应用
|
|
US20190270796A1
(en)
*
|
2016-07-26 |
2019-09-05 |
Nihon University |
Therapeutic agent for periodontitis and compostion for treating periodontitis
|
|
US10439449B2
(en)
*
|
2016-08-10 |
2019-10-08 |
Microsoft Technology Licensing, Llc |
Coupling device modules for inductive data transmission
|
|
MX420249B
(es)
*
|
2016-09-29 |
2025-02-10 |
Mitsubishi Tanabe Pharma Corp |
Agentes de unión monoclonales de cmet, conjugados de fármaco de los mismos y usos de los mismos.
|
|
WO2018069289A1
(en)
|
2016-10-11 |
2018-04-19 |
Medimmune Limited |
Antibody-drug conjugates with immune-mediated therapy agents
|
|
KR102576042B1
(ko)
*
|
2016-10-11 |
2023-09-07 |
아게누스 인코포레이티드 |
항-lag-3 항체 및 이의 사용 방법
|
|
TWI782930B
(zh)
|
2016-11-16 |
2022-11-11 |
美商再生元醫藥公司 |
抗ｍｅｔ抗體，結合ｍｅｔ之雙特異性抗原結合分子及其使用方法
|
|
ES2866348T3
(es)
|
2016-11-16 |
2021-10-19 |
Lilly Co Eli |
Terapia de combinación para el cáncer con mutación o mutaciones de omisión del exón 14 o fenotipo de omisión del exón 14
|
|
HUE054500T2
(hu)
|
2016-11-23 |
2021-09-28 |
Lilly Co Eli |
MET antitest hatóanyag konjugátumok
|
|
BR112019012154A2
(pt)
|
2016-12-14 |
2019-11-12 |
Janssen Biotech, Inc. |
domínios do tipo iii da fibronectina de ligação a cd8a
|
|
EP3554561B1
(en)
|
2016-12-14 |
2023-06-28 |
Janssen Biotech, Inc. |
Cd137 binding fibronectin type iii domains
|
|
EP3554535A4
(en)
|
2016-12-14 |
2020-10-21 |
Janssen Biotech, Inc. |
PD-L1 BINDING FIBRONECTIN TYPE III DOMAINS
|
|
US20180230218A1
(en)
*
|
2017-01-04 |
2018-08-16 |
Immunogen, Inc. |
Met antibodies and immunoconjugates and uses thereof
|
|
CN106986932A
(zh)
*
|
2017-04-06 |
2017-07-28 |
海口市人民医院 |
一种c‑Met表位肽及其应用
|
|
AU2018278730B2
(en)
*
|
2017-05-30 |
2021-02-04 |
Chong Kun Dang Pharmaceutical Corp. |
A novel anti-c-Met antibody and use thereof
|
|
CN109771642B
(zh)
*
|
2017-11-13 |
2022-09-20 |
同济大学苏州研究院 |
c-MET激动型抗体及其用途
|
|
GB201803892D0
(en)
|
2018-03-12 |
2018-04-25 |
Ultrahuman Six Ltd |
C-met binding agents
|
|
SG11202010469QA
(en)
|
2018-05-23 |
2020-11-27 |
Adc Therapeutics Sa |
Molecular adjuvant
|
|
JP7750828B2
(ja)
|
2019-09-16 |
2025-10-07 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
免疫ｐｅｔ撮像のための放射標識されたｍｅｔ結合タンパク質
|
|
US11781138B2
(en)
|
2019-10-14 |
2023-10-10 |
Aro Biotherapeutics Company |
FN3 domain-siRNA conjugates and uses thereof
|
|
US12491255B2
(en)
|
2019-10-14 |
2025-12-09 |
Aro Biotherapeutics Company |
EPCAM binding fibronectin type III domains
|
|
WO2021076546A1
(en)
|
2019-10-14 |
2021-04-22 |
Aro Biotherapeutics Company |
Cd71 binding fibronectin type iii domains
|
|
CN115297889A
(zh)
|
2020-09-01 |
2022-11-04 |
荣昌生物制药(烟台)股份有限公司 |
抗c-Met抗体药物偶联物及其应用
|
|
US20230372528A1
(en)
|
2020-10-16 |
2023-11-23 |
University Of Georgia Research Foundation, Inc. |
Glycoconjugates
|
|
EP4494660A3
(en)
*
|
2021-02-03 |
2025-04-16 |
Mythic Therapeutics, Inc. |
Anti-met antibodies and uses thereof
|
|
GB202102396D0
(en)
|
2021-02-19 |
2021-04-07 |
Adc Therapeutics Sa |
Molecular adjuvant
|
|
BR112023020801A2
(pt)
|
2021-04-08 |
2023-12-12 |
Byondis Bv |
Anticorpo ou fragmento de ligação ao antígeno, conjugado anticorpo-fármaco, composição farmacêutica, e, combinação de um anticorpo ou fragmento de ligação ao antígeno, um conjugado anticorpo-fármaco ou uma composição farmacêutica
|
|
US12239710B2
(en)
|
2021-04-14 |
2025-03-04 |
Aro Biotherapeutics Company |
FN3 domain-siRNA conjugates and uses thereof
|
|
IL307582A
(en)
|
2021-04-14 |
2023-12-01 |
Aro Biotherapeutics Company |
CD71-binding domains of the fibronectin type
|
|
CN113788895B
(zh)
*
|
2021-10-14 |
2023-09-15 |
陕西健吉跃生物科技有限公司 |
一种兔多克隆抗体及其制备方法和应用
|
|
CN117980327A
(zh)
|
2021-11-03 |
2024-05-03 |
杭州多禧生物科技有限公司 |
抗体的特异性偶联
|
|
IL324556A
(en)
|
2023-05-19 |
2026-01-01 |
Servier Lab |
Anti-met antibodies, antibody-drug conjugates, compositions and uses thereof
|
|
CN121969654A
(zh)
*
|
2023-08-02 |
2026-05-01 |
百泰生物药业有限公司 |
EGFR/c-Met双特异性抗体及其应用
|